Liqiang Derek Tou, MD,PhD

Liqiang Derek Tou, MD, PhD has worked in a variety of roles since 2004. Liqiang Derek began their career as a Research Investigator at Novartis in 2004, followed by a Scientist role at Millennium Pharmaceuticals in 2006. In 2012, they became President & CEO of MandarinArk Corp, where they were responsible for educating American kids for the Chinese market. In 2014, they were appointed President & CEO of the Sino-American Medical Association. In 2018, they became Chief of Medical Strategy at Medebound, LLC, and in 2019 they became Cofounder & COO of EarthHunt Trading Company, LLC.

Liqiang Derek Tou, MD,PhD began their educational journey in 2006 when they obtained their MBA in Entrepreneurship/Entrepreneurial Studies from Babson College. Liqiang Derek then went on to receive a Doctor of Philosophy (Ph.D.) in Molecular Pharmacology from Peking University in 1999.